Acknowledgment
- PDF / 60,858 Bytes
- 2 Pages / 612.28 x 790.87 pts Page_size
- 25 Downloads / 180 Views
Mol Diagn Ther 2009; 13 (6): 347-348 1177-1062/09/0006-0347/$49.95/0
ยช 2009 Adis Data Information BV. All rights reserved.
Dear Reader, As we reach the final issue of the year for Molecular Diagnosis & Therapy, we hope that you have found the articles published throughout 2009 to be both interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up-to-date with topical issues in molecular diagnostics, pharmacogenomics, and personalized medicine in 2010. This year, Molecular Diagnosis & Therapy was among a number of our titles achieving substantial gains in ISI impact factors, increasing 54% to 2.14. The impact factor of Clinical Drug Investigation increased to 1.3 (an increase of over 100%), Drugs increased to 4.13, and PharmacoEconomics increased to 2.8. Clinical Pharmacokinetics also registered an increase in its impact factor. We were delighted this year to launch our new interactive online platform, AdisOnline, which we hope will help you navigate our content. The platform provides many new features, including access to featured articles and collections, ability to see the most viewed and e-mailed articles across all titles, and many personalization features. The platform also allows exporting of figures to PowerPoint. Adis has been providing quality content to healthcare professionals for nearly 40 years. This year saw several of our titles celebrate major milestones: Sports Medicine (25 years), Clinical Drug Investigation (20 years), CNS Drugs and BioDrugs (15 years), and Pediatric Drugs (10 years). In 2010, the American Journal of Clinical Dermatology will celebrate its 10-year anniversary. In 2011, many more of our titles will have major anniversaries. Last, but not least, we would like to say a big thank you to all of the authors who have contributed articles to Molecular Diagnosis & Therapy in the last 12 months. Without their hard work and diligence, we would not have been able to publish the journal. The quality of published articles reflects also the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals, who acted as referees for articles published in Molecular Diagnosis & Therapy in 2009:
S. Badve, USA H. Bang, USA R.M. Benoit, USA R. Bhargava, USA M. Camilleri, USA M.A. Campos, USA J.R. Connor, USA D. de Jong, the Netherlands C. de Mendoza, Spain R. Delwel, the Netherlands J.F. Demarest, USA M. Di Michele, Italy L.B. Dustin, USA J.L. Ebersole, USA L. Ekstrom, Sweden A. Fernandez-Astorga, Spain D. Figgitt, New Zealand R.B. Fillingim, USA A. Gaedigk, USA C.J. Gallagher, USA M. Gomez Lira, Italy C. Guillemette, Canada C.J. Harrison, UK D.W. Hein, USA J. Hong, USA N. Houssami, Australia S. Hummel, UK D.N. Husemoen, Denmark F.E. Jones, USA
R. Jonsson, Norway S.S. Kadkol, USA S. Kathariou, USA
Data Loading...
